GSK plc 6-K: Six-Monthly Bonus Plan Update
Ticker: GLAXF · Form: 6-K · Filed: Nov 13, 2024 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Nov 13, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, bonus-plan, block-listing
TL;DR
GSK plc filed a 6-K for its 2017 Deferred Annual Bonus Plan, covering May-Nov 2024.
AI Summary
GSK plc filed a 6-K report on November 13, 2024, detailing a six-monthly return for the GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan. The report covers the period from May 1, 2024, to November 13, 2024, and is related to block listing activities.
Why It Matters
This filing provides transparency on the company's executive compensation plans and potential share issuances related to bonus awards, which can impact shareholder value.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a bonus plan's six-monthly return and does not indicate any immediate financial distress or significant operational changes.
Key Players & Entities
- GSK plc (company) — Registrant
- GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan (company) — Name of scheme
- 001-15170 (dollar_amount) — Commission File Number
FAQ
What is the purpose of this 6-K filing?
This 6-K filing is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, specifically detailing a Block Listing Six Monthly Return for the GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan.
What period does the six-monthly return cover?
The period of return covered by this filing is from May 1, 2024, to November 13, 2024.
What is the company's principal executive office address?
The company's principal executive office is located at 79 New Oxford Street, London, WC1A 1DG.
Has GSK plc filed or will it file annual reports under Form 20-F or Form 40-F?
Yes, the registrant indicates it files annual reports under cover of Form 20-F.
What were GSK plc's former names?
GSK plc was formerly known as GSK PLC (name change effective May 16, 2022) and prior to that, GlaxoSmithKline PLC (name change effective January 5, 2001).
Filing Stats: 563 words · 2 min read · ~2 pages · Grade level 17 · Accepted 2024-11-13 10:14:32
Filing Documents
- a9631l.htm (6-K) — 45KB
- 0001654954-24-014226.txt ( ) — 46KB
SIGNATURES
SIGNATURES     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.   GSK plc   (Registrant)     Date: November 13, 2024         By:/s/ VICTORIA WHYTE --------------------------       Victoria Whyte   Authorised Signatory for and on   behalf of GSK plc